fluconazole has been researched along with ciclopirox in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.33) | 18.2507 |
| 2000's | 10 (41.67) | 29.6817 |
| 2010's | 11 (45.83) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bahn, YS; Cheong, E; Choi, JW; Jang, BK; Kim, D; Kim, HJ; Kim, S; Lee, DG; Lee, JS; Lee, KT; Lee, MH; Lee, YR; Park, JH; Park, KD; Park, SJ; Seo, KJ; Yeon, SK | 1 |
| Baran, R | 1 |
| Seebacher, C; Süss, K; Vennewald, I | 1 |
| Gupta, AK | 1 |
| Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ | 1 |
| Hube, B; Korting, HC; Kunze, D; Niewerth, M; Schaller, M; Seibold, M | 1 |
| Reinel, D | 1 |
| Bottone, EJ; Cohen, S; Krishtul, A; Phelps, R; Stebbins, WG | 1 |
| de Assis Santos, D; Figueiredo, VT; Hamdan, JS; Resende, MA | 1 |
| Carrillo-Muñoz, AJ; Del Valle, O; Eraso, E; Ezkurra, PA; Giusiano, G; Guardia, C; Hernández-Molina, JM; Quindós, G; Santos, P; Tur-Tur, C | 1 |
| Cruz, AR; Gallin, JI; Huang, CY; Zarember, KA | 1 |
| Budihardja, D; Freund, V; Mayser, P | 1 |
| Vera-Cabrera, L; Welsh, E; Welsh, O | 1 |
| Ayadi, A; Boudaya, S; Cheikhrouhou, F; Makni, F; Neji, S; Sellami, H; Turki, H | 1 |
| Beikert, FC; Clad, A; Koeninger, A; Le, MT; Technau, K | 1 |
| Pajaziti, L; Vasili, E | 1 |
| Borelli, C; Jäckel, A; Müller, J; Polak, A; Schaller, M; Seidl, HP | 1 |
| Rosen, T; Stein Gold, LF | 1 |
| Chakrabarti, A; Dogra, S; Mushtaq, K; Narang, T; Paul, RA; Rudramurthy, SM; Shankarnarayan, SA; Shaw, D | 1 |
| Lipner, SR; Scher, RK | 1 |
4 review(s) available for fluconazole and ciclopirox
| Article | Year |
|---|---|
Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Arthrodermataceae; Ciclopirox; Costs and Cost Analysis; Drug Costs; Economics, Pharmaceutical; Female; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Male; Models, Economic; Naphthalenes; Onychomycosis; Pyridones; Randomized Controlled Trials as Topic; Terbinafine; United States | 2000 |
Toenail onychomycosis in diabetic patients: issues and management.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Ciclopirox; Comorbidity; Diabetes Mellitus; Diabetic Foot; Drug Interactions; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Pyridones; Risk Factors; Terbinafine; Therapies, Investigational; Treatment Outcome | 2009 |
Onychomycosis.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2010 |
Onychomycosis: Treatment and prevention of recurrence.
Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Fluconazole; Humans; Itraconazole; Laser Therapy; Nanoparticles; Onychomycosis; Photochemotherapy; Plasma Gases; Prognosis; Pulse Therapy, Drug; Risk Factors; Secondary Prevention; Severity of Illness Index; Terbinafine; Triazoles | 2019 |
1 trial(s) available for fluconazole and ciclopirox
| Article | Year |
|---|---|
Treatment of Onychomycosis - a Clinical Study.
Topics: Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pulse Therapy, Drug; Pyridones; Terbinafine | 2015 |
19 other study(ies) available for fluconazole and ciclopirox
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Optimization and Evaluation of Novel Antifungal Agents for the Treatment of Fungal Infection.
Topics: Animals; Antifungal Agents; Cell Wall; Drug Evaluation, Preclinical; Drug Synergism; Female; Fungi; Humans; Male; Mice; Microbial Sensitivity Tests; Mycoses; Rats, Sprague-Dawley | 2021 |
[New treatments of onychomycoses].
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Ciclopirox; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Morpholines; Onychomycosis; Pyridones | 1992 |
Case report. Folliculitis barbae caused by Candida albicans.
Topics: Adult; Animals; Antifungal Agents; Candidiasis, Cutaneous; Ciclopirox; Fluconazole; Folliculitis; Humans; Male; Pyridones | 1999 |
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole | 2000 |
Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors.
Topics: 2,2'-Dipyridyl; Antifungal Agents; Blotting, Northern; Candida albicans; Chlorides; Ciclopirox; Cloning, Molecular; Drug Interactions; Ferric Compounds; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Hydrogen Peroxide; Iron; Iron Chelating Agents; Membrane Transport Proteins; Microscopy, Electron; Oxidoreductases; Pyridones; Reverse Transcriptase Polymerase Chain Reaction; RNA, Fungal; Sequence Alignment; Up-Regulation; Virulence Factors | 2003 |
[Onychomycosis].
Topics: Antifungal Agents; Ciclopirox; Debridement; Diagnosis, Differential; Drug Therapy, Combination; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Morpholines; Mycological Typing Techniques; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Time Factors | 2004 |
Cutaneous adiaspiromycosis: a distinct dermatologic entity associated with Chrysosporium species.
Topics: Adult; Antifungal Agents; Chrysosporium; Ciclopirox; Dermatomycoses; Drug Therapy, Combination; Fluconazole; Heart Transplantation; Humans; Immunocompromised Host; Male; Pyridones | 2004 |
Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Ciclopirox; Fluconazole; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyridones; Terbinafine | 2007 |
In vitro antifungal activity of sertaconazole nitrate against recent isolates of onychomycosis causative agents.
Topics: Antifungal Agents; Arthrodermataceae; Ciclopirox; Dose-Response Relationship, Drug; Fluconazole; Fungi; Humans; Imidazoles; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Thiophenes; Yeasts | 2008 |
Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Ciclopirox; Deferiprone; Drug Combinations; Fluconazole; Iron Chelating Agents; Ketoconazole; Microbial Sensitivity Tests; Pyridones | 2009 |
First case of Trichophyton soudanense isolated in Tunisia.
Topics: Adult; Antifungal Agents; Ciclopirox; Cote d'Ivoire; Econazole; Fluconazole; Humans; Male; Nails; Pyridones; Skin; Students; Tinea; Trichophyton; Tunisia | 2010 |
Recurrent vulvovaginal candidosis: focus on the vulva.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Biopsy; Candida albicans; Candidiasis, Vulvovaginal; Ciclopirox; Female; Fluconazole; Histocytochemistry; Humans; Microscopy; Prospective Studies; Pyridones; Recurrence; Skin; Treatment Outcome; Vulva | 2011 |
Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections.
Topics: Antifungal Agents; Candida albicans; Ciclopirox; Epidermophyton; Fluconazole; Hand Dermatoses; Humans; Keratins; Microbial Sensitivity Tests; Morpholines; Nails; Naphthalenes; Onychomycosis; Pyridones; Spores, Fungal; Terbinafine; Trichophyton | 2015 |
Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Treatment Outcome; Triazoles; United States | 2016 |
Mutation in the Squalene Epoxidase Gene of Trichophyton interdigitale and Trichophyton rubrum Associated with Allylamine Resistance.
Topics: Allylamine; Antifungal Agents; Arthrodermataceae; Ciclopirox; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Morpholines; Squalene Monooxygenase; Terbinafine; Trichophyton; Voriconazole | 2018 |